Experimental and mathematical insights on the interactions between poliovirus and a defective interfering genome.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
09 2021
Historique:
received: 07 01 2021
accepted: 28 07 2021
revised: 07 10 2021
pubmed: 28 9 2021
medline: 25 11 2021
entrez: 27 9 2021
Statut: epublish

Résumé

During replication, RNA viruses accumulate genome alterations, such as mutations and deletions. The interactions between individual variants can determine the fitness of the virus population and, thus, the outcome of infection. To investigate the effects of defective interfering genomes (DI) on wild-type (WT) poliovirus replication, we developed an ordinary differential equation model, which enables exploring the parameter space of the WT and DI competition. We also experimentally examined virus and DI replication kinetics during co-infection, and used these data to infer model parameters. Our model identifies, and our experimental measurements confirm, that the efficiencies of DI genome replication and encapsidation are two most critical parameters determining the outcome of WT replication. However, an equilibrium can be established which enables WT to replicate, albeit to reduced levels.

Identifiants

pubmed: 34570820
doi: 10.1371/journal.ppat.1009277
pii: PPATHOGENS-D-21-00004
pmc: PMC8496841
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009277

Subventions

Organisme : NIAID NIH HHS
ID : R41 AI157129
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008284
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI040085
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI144144
Pays : United States
Organisme : NIAID NIH HHS
ID : R41 AI155100
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI036178
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI060537
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trends Cell Biol. 2017 Mar;27(3):201-213
pubmed: 27838086
Trends Microbiol. 2015 Mar;23(3):126-33
pubmed: 25680587
Genes Dev. 1998 Aug 1;12(15):2293-304
pubmed: 9694795
Virology. 1999 Sep 15;262(1):114-28
pubmed: 10489346
Epidemiol Infect. 1990 Jun;104(3):427-41
pubmed: 2140794
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4171-5
pubmed: 8387212
Adv Virus Res. 1954;2:59-79
pubmed: 13228257
Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):
pubmed: 26150667
Virology. 1966 Jun;29(2):179-89
pubmed: 4287327
Q Rev Biol. 1996 Mar;71(1):37-78
pubmed: 8919665
Sci Am. 1993 Jul;269(1):42-9
pubmed: 8337597
Am Nat. 2005 Mar;165(3):364-73
pubmed: 15729666
Trends Parasitol. 2009 Jun;25(6):261-8
pubmed: 19409846
PLoS Pathog. 2015 Sep 03;11(9):e1005122
pubmed: 26336095
Vaccine. 2000 Jun 15;18(25):2895-901
pubmed: 10812233
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8685-9
pubmed: 8078942
J Virol. 2000 Jul;74(14):6394-400
pubmed: 10864650
Cell Host Microbe. 2018 Jan 10;23(1):77-88.e5
pubmed: 29290575
Sci Transl Med. 2015 Jul 22;7(297):297ra114
pubmed: 26203082
J Virol. 2004 Jun;78(11):5799-804
pubmed: 15140977
Annu Rev Microbiol. 1973;27:101-17
pubmed: 4356530
Theor Popul Biol. 1977 Oct;12(2):197-29
pubmed: 929457
Nature. 1970 Apr 25;226(5243):325-7
pubmed: 5439728
Cold Spring Harb Symp Quant Biol. 1962;27:303-9
pubmed: 13954778
J Virol. 1999 Jan;73(1):427-35
pubmed: 9847348
Genes Dev. 1994 Jul 15;8(14):1726-37
pubmed: 7958852
Annu Rev Microbiol. 2010;64:241-56
pubmed: 20825348
Science. 2001 May 11;292(5519):1099-102
pubmed: 11352063
J Virol. 1989 Nov;63(11):4866-74
pubmed: 2552159
Proc Biol Sci. 2017 Jul 26;284(1859):
pubmed: 28747479
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13081-6
pubmed: 25157142
Curr Top Microbiol Immunol. 1981;93:151-207
pubmed: 7026180
Virol J. 2010 Sep 29;7:257
pubmed: 20920247
J Immunol. 1950 Mar;64(3):203-36
pubmed: 15412251
Arch Gesamte Virusforsch. 1966;18(2):231-43
pubmed: 4293028
J Virol. 2013 Jul;87(14):8064-74
pubmed: 23678180
J Virol. 2000 Mar;74(5):2219-26
pubmed: 10666252
PLoS Pathog. 2013;9(6):e1003401
pubmed: 23762027
J Virol. 2013 Feb;87(4):2081-93
pubmed: 23221552
J Virol. 1988 May;62(5):1687-96
pubmed: 2833619
Nature. 2014 Jan 30;505(7485):686-90
pubmed: 24284629
J Mol Biol. 1973 May 25;76(3):345-61
pubmed: 4354478
Curr Protoc Microbiol. 2013;Chapter 15:Unit 15H.1
pubmed: 23686830
Viruses. 2015 Jul 08;7(7):3768-88
pubmed: 26184282
Evol Appl. 2009 Feb;2(1):32-9
pubmed: 25567845
PLoS Pathog. 2017 Oct 12;13(10):e1006650
pubmed: 29023600
J Gen Virol. 2009 Apr;90(Pt 4):888-899
pubmed: 19264636
Proc Biol Sci. 2017 May 17;284(1854):
pubmed: 28490625
Cell Host Microbe. 2014 Jan 15;15(1):36-46
pubmed: 24439896
Biotechnol J. 2015 May;10(5):681-9
pubmed: 25728309
J Gen Microbiol. 1959 Dec;21:498-509
pubmed: 13798559
Cell. 1979 Nov;18(3):759-69
pubmed: 229964
PLoS One. 2013 Sep 05;8(9):e72288
pubmed: 24039749
Trends Ecol Evol. 1992 Apr;7(4):118-21
pubmed: 21235976
Virology. 1988 Sep;166(1):265-70
pubmed: 2842953
EMBO J. 1990 Jun;9(6):2011-6
pubmed: 2161336
Virology. 1990 Jul;177(1):1-10
pubmed: 2191494
Cell. 2015 Feb 12;160(4):619-630
pubmed: 25679758
Virology. 2015 Aug;482:28-31
pubmed: 25817402
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13774-13779
pubmed: 29233945
Mol Cell. 2001 Mar;7(3):581-91
pubmed: 11463383
Genetics. 1998 Oct;150(2):523-32
pubmed: 9755186
J Virol. 1971 Apr;7(4):478-85
pubmed: 4329564
Nat Protoc. 2014 Jul;9(7):1760-9
pubmed: 24967624
Virus Res. 2016 Jun 15;218:86-95
pubmed: 27208847
PLoS One. 2011 Apr 29;6(4):e19447
pubmed: 21559384
Nature. 1999 Apr 1;398(6726):441-3
pubmed: 10201376
J Mol Biol. 1986 Dec 5;192(3):473-87
pubmed: 3031313
Science. 1982 Mar 26;215(4540):1577-85
pubmed: 7041255
Elife. 2015 Jan 30;4:
pubmed: 25635405

Auteurs

Yuta Shirogane (Y)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.
Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Elsa Rousseau (E)

Department of Industrial and Applied Genomics, AI and Cognitive Software Division, IBM Almaden Research Center, San Jose, California, United States of America.
NSF Center for Cellular Construction, University of California, San Francisco, California, United States of America.

Jakub Voznica (J)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.
ENS Cachan, Université Paris-Saclay, Cachan, France.

Yinghong Xiao (Y)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.

Weiheng Su (W)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.
National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China.

Adam Catching (A)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.

Zachary J Whitfield (ZJ)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.

Igor M Rouzine (IM)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.
Laboratoire de Biologie Computationnelle et Quantitative, Sorbonne Universite, Institut de Biologie Paris-Seine, Paris, France.

Simone Bianco (S)

Department of Industrial and Applied Genomics, AI and Cognitive Software Division, IBM Almaden Research Center, San Jose, California, United States of America.
NSF Center for Cellular Construction, University of California, San Francisco, California, United States of America.

Raul Andino (R)

Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH